Lockton Australia Rides for Research
From 16-17 October, Team Lockton for MACA will be among 150 corporate and community teams embarking on a 200km ride over two days, to raise much-needed funds for cancer research.
Setting off on the journey from Perth’s Optus Stadium, teams will make their way down through WA’s scenic foothills road system all the way to the Mandurah foreshore, where a ceremony will be held to celebrate the year’s fundraising campaign. The following day, riders will make their way back along the metropolitan coastal plain, arriving back at the Perkins, the spiritual home of the MACA Cancer 200 Ride for Research.
The Ride, which is in its tenth year, is Australia’s biggest fundraising bike ride, having raised more than $40M for cancer research in Western Australia.
The funds raised from the event will support several endeavours, including a brain cancer project focused on turning off genes designed to repair cancer cells, and research into new modes of cancer drug delivery to treat cancer cells more quickly.
At this stage of the fundraising campaign, Team Lockton for MACA has raised over $50,000, which equates to more than 190 hours of research.
Gerry Favory, Team Captain and National Manager, Corporate Risks & Mining, completed his first ride in 2014.
“For me, it started as a recreational ride given my passion for riding and wanting to play a small part in something much bigger than myself, but since my father was diagnosed with prostate cancer and several friends were affected by the disease, it’s become about honouring the people touched by cancer and the people researching the disease.”
“It’s my hope that the funds we raise can save lives and create better outcomes for people living with cancer. Time is a gift and it’s something I hope we can give to more families like mine,” he adds.
In 2017, Favory was joined by Richard Shillington, National Manager of Construction Projects, before the team grew to nine in 2018.
This year Favory is thrilled to be leading a team of 13 colleagues and friends of Lockton, among them, Lockton’s Chief Operating Officer, Andrew Wait; State Executive for Western Australia, Nick Turley; National Manager, Corporate Risks, Peter Barron; Corporate Risks Manager, Ross Corvaia; Life, Accident and Health Consultant, Mark Kelt; and Client Service Officer, Tom Wheeler.
Steve Currie, Partner Relationship Manager at the Perkins says the Institute is driven to end this terrible disease for good.
“Our focus is in finding kinder treatments with better outcomes for people living with the most hard to treat cancers. By having researchers working side by side, breakthroughs in treatment through collaboration are made more readily, this is unique to the Perkins,” he explains.
If you would like to learn more about the impact of the MACA Cancer 200 Ride for Research, or if you’d like to make a donation to Team Lockton for MACA, visit, https://www.cancer200.org.au/fundraisers/LocktonforMACA742
ABOUT THE PERKINS
The Harry Perkins Institute of Medical Research is WA’s largest research facility devoted to finding answers for the major diseases affecting our community. The Perkins is driven to find better outcomes for people affected by cancer, heart disease, diabetes and rare genetic diseases.
• 1 in 2 Australian men and women will be diagnosed with cancer by the age of 85.
• Cancer is a leading cause of death in Australia – almost 50,000 deaths from cancer are estimated for 2021.
• 69% of people diagnosed with cancer in Australia are still alive five years after a cancer diagnosis.
• Make cancer non-lethal
• Idenitfy and treat those with the greatest risk of heart disease and diabetes
• Lessen risk of rare genetic disease through detection and treatment
• Use big data and biomedical engineering to orchestrate better, kinder health outcomes